Cargando…
Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients
BACKGROUND AIMS. TissueGene-C (TG-C) represents a cell-mediated gene therapy for localized delivery of allogeneic chondrocytes expressing transforming growth factor (TGF)-β1 directly to the damaged knee joint. Untransduced human chondrocytes (hChonJ cells) have also been incorporated into the TG-C p...
Autores principales: | Ha, Chul-Won, Noh, Moon Jong, Choi, Kyoung Baek, Lee, Kwan Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793276/ https://www.ncbi.nlm.nih.gov/pubmed/22242865 http://dx.doi.org/10.3109/14653249.2011.629645 |
Ejemplares similares
-
Current Advances in Retroviral Gene Therapy
por: Yi, Youngsuk, et al.
Publicado: (2011) -
Type II collagen and glycosaminoglycan expression induction in primary human chondrocyte by TGF-β1
por: Yoon, Hyun Joo, et al.
Publicado: (2015) -
Syncytin 1 dependent horizontal transfer of marker genes from retrovirally transduced cells
por: Uygur, Berna, et al.
Publicado: (2019) -
Antigenic and immunogenic properties of chondrocytes. Implications for chondrocyte therapeutic transplantation and pathogenesis of inflammatory and degenerative joint diseases
por: Osiecka-Iwan, Anna, et al.
Publicado: (2018) -
A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders
por: Schipper, Hyman M., et al.
Publicado: (2015)